PMH10 COSTS AND EFFECTS OF RISPERDAL CONSTATM IN COMPARISON TO CONVENTIONAL DEPOT AND SHORT-ACTING ATYPICAL FORMULATIONS IN GERMANY
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61767-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)61767-6/fulltext
Title :
PMH10 COSTS AND EFFECTS OF RISPERDAL CONSTATM IN COMPARISON TO CONVENTIONAL DEPOT AND SHORT-ACTING ATYPICAL FORMULATIONS IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61767-6&doi=10.1016/S1098-3015(10)61767-6
First page :
Section Title :
Open access? :
No
Section Order :
211